Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma. - Wikidata - awgldk - TriplyDB

Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma.

Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma.

http://www.wikidata.org/entity/Q50793851

about

Update of the human and mouse Fanconi anemia genes Whole exome sequencing reveals concomitant mutations of multiple FA genes in individual Fanconi anemia patients.Molecular pathways: turning proteasomal protein degradation into a unique treatment approach.Fanconi anaemia, BRCA2 mutations and childhood cancer: a developmental perspective from clinical and epidemiological observations with implications for genetic counselling.Fanconi anaemia: genetics, molecular biology, and cancer – implications for clinical management in children and adults.Advances in the understanding of Fanconi Anemia Complementation Group D2 Protein (FANCD2) in human cancer.Next-generation sequencing reveals germline mutations in an infant with synchronous occurrence of nephro- and neuroblastoma.Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruption.

P2860

Q26776461-AEAF606B-5346-420E-9896-DCD520131A77 Q33686055-D50DE546-25CB-4416-80B5-CC9FD08D80DA Q36436413-6DD8A2BD-3A73-44EE-903A-AA120E0723B0 Q38164646-4E3F329D-C589-447C-BC7D-CE21E47902F1 Q38259296-F6D465F7-B1DF-4FF8-AE47-00228900580D Q38660676-3E6F2244-C194-4583-8AFD-1318878D4EB9 Q38855176-77FD396F-D630-4375-905E-0BB5CF94F3E6 Q41084246-9D8521A4-F36F-4807-B986-C16F09EADC7F

P2860

Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma.

http://www.wikidata.org/entity/Q50793851

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Heterozygote FANCD2 mutations ...... l ALL and testicular seminoma.

@en

Heterozygote FANCD2 mutations ...... l ALL and testicular seminoma.

@nl

type

label

Heterozygote FANCD2 mutations ...... l ALL and testicular seminoma.

@en

Heterozygote FANCD2 mutations ...... l ALL and testicular seminoma.

@nl

prefLabel

Heterozygote FANCD2 mutations ...... l ALL and testicular seminoma.

@en

Heterozygote FANCD2 mutations ...... l ALL and testicular seminoma.

@nl

P1433

Q50793851-BAF54B37-8B5A-4779-BF96-4CA456897301

P1476

Q50793851-0B64FE3E-4129-4CAF-A0D3-4CEBB52BE240

P2093

Q50793851-0A9190EB-2B2F-4CAB-82C3-3AA90939F5D6

Q50793851-2EF2D068-2BC2-448B-9C9D-D7BED0E01958

Q50793851-3E9BDFDF-150F-473F-B7D9-167704549BFA

Q50793851-52157A5E-18B5-447E-B041-071C1B0FA6D9

Q50793851-5257E7DE-192C-40CA-BD37-F021A02ACA47

Q50793851-6582D387-90E2-4F64-8FB2-C62B4C4BE08C

Q50793851-6E855C61-76E7-44C6-9980-7635619CF793

Q50793851-750DC867-BA32-4412-873B-FC8539495ECF

Q50793851-829EC2A6-89B3-4BF1-A1E0-D2CDD25013EF

Q50793851-8ED01CE7-C853-4461-9F19-7D6ACE831EA4

P2860

Q50793851-11512A5A-6FD4-4425-BB5F-5957E132A865

Q50793851-12D4C419-4F07-4D65-BF07-FE0AE6CB92B9

Q50793851-1E7FB9CA-3CB2-42B2-B0CC-42DB75778B39

Q50793851-2A79EE3D-86B6-47F2-A920-B273DAE5DC93

Q50793851-4C9FF541-485D-4DBC-B119-497ABB646B63

Q50793851-4F00271B-6AAD-484C-83C9-CEB20C419034

Q50793851-59D5D8E3-E50B-4AE7-A4EC-B2EB7D11FBF0

Q50793851-725B23A3-BEBA-40B6-87D8-5FF16347469D

Q50793851-73A972B3-1044-4D4F-9633-BEFD7D7A295D

Q50793851-7F7BFCA9-D071-4845-AE1E-42D5E001033C

P2888

Q50793851-BD0345E5-58B2-48FF-AED4-F2A815A30E60

P304

Q50793851-511F456F-14CC-4C16-BF9B-D2B6CC773422

P31

Q50793851-4D607564-3FA0-4920-8BC8-3F41AD2A65E0

P356

Q50793851-27A43FD8-6927-4101-8AB3-E2182ED01326

P433

Q50793851-963CC252-2323-4D09-A1A6-DDBD2A1E5492

P478

Q50793851-B4542E15-FC55-4162-B25F-54FA0661516E

P50

Q50793851-0681338F-11C2-4BAA-9607-9D9663506EA0

Q50793851-369728D6-0BA5-497F-9363-7005734D2976

Q50793851-6BA4B050-8CB2-415C-A7F0-92F0EF5D088B

Q50793851-729E8BC3-EA15-4A1F-8B84-BE6B6DA65A06

P577

Q50793851-4427359D-520D-4989-AC57-DA244D0F5195

P698

Q50793851-8B5D4FDF-CCE1-449C-8A63-AACA7CD61AD6

P356

S10689-012-9553-3

P1433

Familial Cancer

P1476

Heterozygote FANCD2 mutations ...... l ALL and testicular seminoma.

@en

P2093

Andrew M Will

http://www.w3.org/2001/XMLSchema#string

Claire Bristow

http://www.w3.org/2001/XMLSchema#string

Davy Rockx

http://www.w3.org/2001/XMLSchema#string

Denise Bonney

http://www.w3.org/2001/XMLSchema#string

Hans Joenje

http://www.w3.org/2001/XMLSchema#string

Joanne Muter

http://www.w3.org/2001/XMLSchema#string

Johan J P Gille

http://www.w3.org/2001/XMLSchema#string

Jonathan Shanks

http://www.w3.org/2001/XMLSchema#string

Josephine Dorsman

http://www.w3.org/2001/XMLSchema#string

Kate Chandler

http://www.w3.org/2001/XMLSchema#string

P2860

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

Mutations of the SLX4 gene in Fanconi anemia

Mutations in BRIP1 confer high risk of ovarian cancer

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.

Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.

Fanconi anaemia and leukaemia - clinical and molecular aspects.

Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.

Inherited susceptibility to common cancers.

The genetic and molecular basis of Fanconi anemia.

P2888

s10689-012-9553-3

P304

661-665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10689-012-9553-3

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Gordon Strathdee

Anthony D Whetton

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22829014

http://www.w3.org/2001/XMLSchema#string